Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy-论文-万方医学网

首页> > Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy

Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy

导出原文传递

翻译打印收藏纠错

作者： Zattarin, Emma ^[1] ; Manglaviti, Sara ; Apollonio, Giulia ; Beninato, Teresa ; Mazzeo, Laura ; Massa, Giacomo ; Bottiglieri, Achille ; Galli, Edoardogregorio ; De Toma, Alessandro ; Occhipinti, Mario ; Brambilla, Marta ; Ferrara, Roberto ; Ganzinelli, Monica ; Proto, Claudia ; Garassino, Marina Chiara ; de Braud, Filippo ; Lo Russo, Giuseppe ; Prelaj, Arsela

作者单位： Dept Med Oncol,Fdn IRCCS Ist Nazl Tumori ^[1]

关键词 advanced non-small-cell lung cancer chemo-immunotherapy EPSILoN score first-line setting neutrophil-to-lymphocyte ratio prognostic score PLUS CHEMOTHERAPY BLOOD BIOMARKERS PEMBROLIZUMAB IMMUNOTHERAPY OUTCOMES TRIAL

发布时间 2022-12-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy

相似文献

相关期刊

检索历史清除